---
title: "Scholar Rock files for up to $200 million at-the-market stock offering"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295109643.md"
description: "Scholar Rock has filed for an at-the-market equity program to sell up to $200 million of common stock through Jefferies. This new prospectus supplement replaces a prior one terminated on November 14, 2025. To date, net proceeds from the ATM program total approximately $257.7 million."
datetime: "2026-08-06T12:50:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295109643.md)
  - [en](https://longbridge.com/en/news/295109643.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295109643.md)
---

# Scholar Rock files for up to $200 million at-the-market stock offering

-   Scholar Rock launched a refreshed at-the-market equity program to sell up to USD 200 million of common stock through Jefferies. \* The new prospectus supplement replaces the prior November 14, 2025 supplement, which was terminated. \* Net proceeds raised under the ATM program total about USD 257.7 million to date. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scholar Rock Holding Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-091702), on August 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [SRRK.US](https://longbridge.com/en/quote/SRRK.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)

## Related News & Research

- [Scholar Rock Readies for Apitegromab Launch Amid Risks](https://longbridge.com/en/news/295726510.md)
- [Scholar Rock Overcomes Manufacturing Hurdle to Keep Lead Drug FDA Review on Schedule](https://longbridge.com/en/news/295429730.md)
- [DISCO Launches Advanced Research for Deep, Agentic AI Powered eDiscovery and Fact Investigation | LAW Stock News](https://longbridge.com/en/news/295801307.md)
- [Scholar Rock: Strengthened Regulatory Path and Cash Position Underscore Attractive Risk‑Reward Ahead of Apitegromab PDUFA](https://longbridge.com/en/news/295354098.md)
- [BTQ Technologies announces shareholder webinar on Q2 2026 results](https://longbridge.com/en/news/295646141.md)